Lionco Pharmaceutical Group Co.,Ltd. (SHA:603669)

China · Delayed Price · Currency is CNY

5.04

-0.16 (-3.08%)

Jul 30, 2026, 3:00 PM CST

SHA:603669 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	358.9	322.48	379.78	196.83	289.26	740.33
Revenue Growth	1.66%	-15.09%	92.95%	-31.95%	-60.93%	-26.04%
Gross Profit	148.28	137.36	173.26	86.96	194.74	584.62
Operating Income	-91.75	-108.26	-109.27	-169.99	-177.04	38.42
Net Income	-171.66	-193.24	-130.76	-151.5	-195.86	65.9
Earnings Per Share	-0.24	-0.27	-0.18	-0.21	-0.27	0.09
EPS Growth	-	-	-	-	-	-57.14%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	156.84	168.83	285.31	734.01	965.28	1,566
Total Debt	317	291.68	264.26	565.61	619.97	949.22
Net Cash (Debt)	-160.16	-122.85	21.05	168.4	345.3	616.84
Net Cash Growth	-	-	-87.50%	-51.23%	-44.02%	-28.25%
Net Cash Per Share	-0.22	-0.17	0.03	0.23	0.48	0.86

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-148.53	-132.87	-110.89	-37.87	-66.36	128.5
Capital Expenditures	-4.06	-2.68	-8.85	-23.13	-42.84	-54.82
Free Cash Flow	-152.59	-135.55	-119.74	-61.01	-109.2	73.69
Free Cash Flow Growth	-	-	-	-	-	13.60%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	41.32%	42.59%	45.62%	44.18%	67.32%	78.97%
Operating Margin	-25.57%	-33.57%	-28.77%	-86.36%	-61.20%	5.19%
Pretax Margin	-47.82%	-60.01%	-33.63%	-76.69%	-65.27%	9.52%
Profit Margin	-47.83%	-59.92%	-34.43%	-76.97%	-67.71%	8.90%
FCF Margin	-42.52%	-42.03%	-31.53%	-30.99%	-37.75%	9.95%

Dividends

Fiscal Year	FY 2021
Period Ending	Dec '21 Dec 31, 2021
Dividend Per Share	0.100
Dividend Per Share Growth	-50.00%
Dividend Yield	1.02%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	-	-	109.32
Forward PE	-	16.63	16.63	16.63	16.63	16.63
P/FCF Ratio	-	-	-	-	-	97.77
PS Ratio	10.19	9.95	9.73	20.26	14.31	9.73